GRTX logo

Galera Therapeutics, Inc. (GRTX)

Profile

Full Name

Galera Therapeutics, Inc.

Ticker

NASDAQ: GRTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 7, 2019

Indexes

Not included

Website

https://www.galeratx.com

Employees

3

Key Details

Price

$0.02(6.25%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.35(73.84% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.02
    GRTX price is $0.02

    30-Day Relative Volume

    0.07
    GRTX 30-day relative volume is 0.07

    Price Performance

    Price Most Recent Change

    +6.25%
    GRTX price was up +6.25% on Oct 17, 2025

    Price YTD Change

    -63.04%
    GRTX price is down -63.04% since January 1st

    Price 1-Year Change

    -68.52%
    GRTX price is down -68.52% year-on-year

    Price 3-Year Change

    -98.98%
    GRTX price is down -98.98% over the past 3 years

    Price Range

    Price All-Time High

    $19.50
    GRTX price is currently -99.91% below its historical high of $19.50

    Price 3-Year Low

    $0.01
    GRTX price is currently +13.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.28M
    GRTX market cap is $1.28 million

    Market Cap 3-Year Change

    -97.12%
    GRTX market cap is down -97.12% over the past 3 years

    Market Cap All-Time High

    $438.42M
    GRTX market cap is currently -99.71% below its historical high of $438.42 million

    Market Cap Sector Percentile

    4.47%
    GRTX market cap is higher than 4.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +38.74%
    GRTX shares outstanding is up +38.74% year-on-year

    Shares Outstanding 3-Year Change

    +181.24%
    GRTX shares outstanding is up +181.24% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.54
    GRTX beta is 0.54

    200-day SMA

    $0.03
    GRTX price is currently -41.18% below its 200-day simple moving average

    50-day SMA

    $0.02
    GRTX price is currently -13.27% below its 50-day simple moving average

    14-Day RSI

    50.00
    GRTX 14-day relative strength index is 50.00

    Volume

    0.07
    GRTX 30-day relative volume is 0.07

    ATR

    $0.00
    GRTX average true range is $0.00

    10-day Historical Volatility

    83.00%
    GRTX 10-day historical volatility is 83.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    GRTX annual revenue is $0.00

    Revenue Analysts Estimate

    -
    GRTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    GRTX annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.76%
    GRTX annual revenue is higher than 28.76% of companies in Healthcare sector

    EPS

    EPS

    -$0.35
    GRTX annual earnings per share is -$0.35

    EPS Analysts Estimate

    -
    GRTX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    +73.84%
    GRTX annual earnings per share is up +73.84% year-on-year

    EPS Sector Percentile

    71.31%
    GRTX annual earnings per share is higher than 71.31% of companies in Healthcare sector

    Profit

    Gross Profit

    -$20.00K
    GRTX annual gross profit is -$20.00 thousand

    Gross Margin

    -
    GRTX annual gross profit margin value is unknown

    Operating Profit

    -$14.15M
    GRTX annual operating income is -$14.15 million

    Operating Margin

    -
    GRTX annual operating profit margin value is unknown

    Net Income

    -$18.96M
    GRTX annual net profit is -$18.96 million

    Net Margin

    -
    GRTX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $14.15M
    GRTX annual total expenses is $14.15 million

    Operating Expenses

    $14.15M
    GRTX annual total operating expenses is $14.15 million

    Cost Of Goods Sold

    $20.00K
    GRTX annual cost of goods sold is $20.00 thousand

    Selling, General & Administrative Expenses

    $11.00M
    GRTX annual SG&A is $11.00 million

    Depreciation & Amortization

    $20.00K
    GRTX annual D&A is $20.00 thousand

    Interest Expense

    $0.00
    GRTX annual interest expense is $0.00

    Income Tax

    -$203.00K
    GRTX annual income tax is -$203.00 thousand

    EBIT & EBITDA

    EBIT

    -$19.16M
    GRTX annual earnings before interest & taxes is -$19.16 million

    EBITDA

    -$19.14M
    GRTX annual EBITDA is -$19.14 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $10.10M
    GRTX annual total assets is $10.10 million

    Non Current Assets

    $100.00K
    GRTX annual long term assets is $100.00 thousand

    Current Assets

    $10.00M
    GRTX annual total current assets is $10.00 million

    Cash and Cash Equivalents

    $8.29M
    GRTX annual cash & cash equivalents is $8.29 million

    Accounts Receivable

    -
    GRTX annual accounts receivable value is unknown

    Inventory

    $0.00
    GRTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $153.77M
    GRTX annual total liabilities is $153.77 million

    Long Term Liabilities

    $152.10M
    GRTX annual total long term liabilities is $152.10 million

    Current Liabilities

    $1.67M
    GRTX annual current liabilities is $1.67 million

    Accounts Payable

    $1.27M
    GRTX annual accounts payable is $1.27 million

    Debt

    Total Debt

    $151.05M
    GRTX annual total debt is $151.05 million

    Total Debt 1-Year Change

    -0.82%
    GRTX annual total debt is down -0.82% year-on-year

    Long Term Debt

    $151.05M
    GRTX annual long term debt is $151.05 million

    Short Term Debt

    $0.00
    GRTX annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    -$143.67M
    GRTX annual stockholders equity is -$143.67 million

    Book Value

    -$148.04M
    GRTX annual book value is -$148.04 million

    Retained Earnings

    -$456.36M
    GRTX annual retained earnings is -$456.36 million

    Working Capital

    $8.34M
    GRTX annual working capital is $8.34 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$12.14M
    GRTX annual cash from operations is -$12.14 million

    Cash From Operations 1-Year Change

    +72.92%
    GRTX annual cash from operations is up +72.92% year-on-year

    Cash From Investing

    -$46.00K
    GRTX annual cash from investing is -$46.00 thousand

    Cash From Investing 1-Year Change

    -100.17%
    GRTX annual cash from investing is down -100.17% year-on-year

    Cash From Financing

    $2.22M
    GRTX annual cash from financing is $2.22 million

    Cash From Financing 1-Year Change

    -92.94%
    GRTX annual cash from financing is down -92.94% year-on-year

    CAPEX

    CAPEX

    $0.00
    GRTX annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    GRTX annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$12.14M
    GRTX annual free cash flow is -$12.14 million

    Free Cash Flow 1-Year Change

    +72.96%
    GRTX annual free cash flow is up +72.96% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    GRTX annual gross profit margin value is unknown

    Operating Margin

    -
    GRTX annual operating profit margin value is unknown

    Net Margin

    -
    GRTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -104.61%
    GRTX annual return on assets is -104.61%

    ROE

    13.19%
    GRTX annual return on equity is 13.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    GRTX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    GRTX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -0.01
    GRTX price to book ratio is -0.01

    PB Ratio Sector Percentile

    15.83%
    GRTX price to book ratio is higher than 15.83% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    GRTX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    GRTX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $147.10M
    GRTX enterprise value is $147.10 million

    Enterprise Value Sector Percentile

    50.13%
    GRTX enterprise value is higher than 50.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -17.39
    GRTX EV/EBITDA is -17.39

    EV/EBITDA Sector Percentile

    9.03%
    GRTX EV/EBITDA is higher than 9.03% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.00
    GRTX annual current ratio is 6.00

    Quick Ratio

    6.00
    GRTX annual quick ratio is 6.00

    Leverage

    Debt To Equity

    -1.05
    GRTX annual debt to equity ratio is -1.05

    Interest Coverage Ratio

    -
    GRTX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    GRTX piotroski f-score value is unknown

    Altman Z-Score

    -68.52
    GRTX altman z-score is -68.52

    Analyst ratings

    Recent major analysts updates

    Aug 29, 23 Citigroup
    Neutral
    Aug 16, 23 HC Wainwright & Co.
    Neutral
    Aug 10, 23 Piper Sandler
    Neutral
    Jul 17, 23 HC Wainwright & Co.
    Buy
    Mar 22, 23 HC Wainwright & Co.
    Buy
    Feb 21, 23 Piper Sandler
    Overweight
    Feb 16, 23 HC Wainwright & Co.
    Buy
    Feb 16, 23 B of A Securities
    Buy
    May 27, 22 B of A Securities
    Underperform
    Dec 20, 21 Citigroup
    Buy

    Institutional Ownership

    Screeners with GRTX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Galera Therapeutics, Inc.?
    • Does Galera Therapeutics, Inc. pay dividends?
    • What sector is Galera Therapeutics, Inc. in?
    • What industry is Galera Therapeutics, Inc. in?
    • What country is Galera Therapeutics, Inc. based in?
    • When did Galera Therapeutics, Inc. go public?
    • Is Galera Therapeutics, Inc. in the S&P 500?
    • Is Galera Therapeutics, Inc. in the NASDAQ 100?
    • Is Galera Therapeutics, Inc. in the Dow Jones?
    • When was Galera Therapeutics, Inc.'s last earnings report?
    • When does Galera Therapeutics, Inc. report earnings?

    What is the ticker symbol for Galera Therapeutics, Inc.?

    The ticker symbol for Galera Therapeutics, Inc. is NASDAQ:GRTX

    Does Galera Therapeutics, Inc. pay dividends?

    No, Galera Therapeutics, Inc. does not pay dividends

    What sector is Galera Therapeutics, Inc. in?

    Galera Therapeutics, Inc. is in the Healthcare sector

    What industry is Galera Therapeutics, Inc. in?

    Galera Therapeutics, Inc. is in the Biotechnology industry

    What country is Galera Therapeutics, Inc. based in?

    Galera Therapeutics, Inc. is headquartered in United States

    When did Galera Therapeutics, Inc. go public?

    Galera Therapeutics, Inc.'s initial public offering (IPO) was on November 7, 2019

    Is Galera Therapeutics, Inc. in the S&P 500?

    No, Galera Therapeutics, Inc. is not included in the S&P 500 index

    Is Galera Therapeutics, Inc. in the NASDAQ 100?

    No, Galera Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Galera Therapeutics, Inc. in the Dow Jones?

    No, Galera Therapeutics, Inc. is not included in the Dow Jones index

    When was Galera Therapeutics, Inc.'s last earnings report?

    Galera Therapeutics, Inc.'s most recent earnings report was on November 9, 2022

    When does Galera Therapeutics, Inc. report earnings?

    The date for Galera Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page